Gland Pharma Limited
GLAND
Rang in aandelen
#3302
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Aandeelprijs
$32.32
Marktkapitalisatie
$5.33B
Verandering (1 dag)
-3.01%
Verandering (1 jaar)
47.99%
Land
IN
Handel Gland Pharma Limited (GLAND)
Categorie
Healthcare
P/B-ratio voor Gland Pharma Limited (GLAND)
P/B-ratio op October 2026 TTM: 4.84
Volgens de meest recente financiële rapporten en aandelenkoers van Gland Pharma Limited is de huidige P/B-ratio (TTM) 4.84. Eind 2024 had het bedrijf een P/B-ratio van 3.43.
P/B-ratiohistoriek voor Gland Pharma Limited van 2017 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 4.84 | 72.92% |
| 2025 | 2.80 | -18.34% |
| 2024 | 3.43 | 30.55% |
| 2023 | 2.62 | -65.05% |
| 2022 | 7.51 | 13.10% |
| 2021 | 6.64 | -14.17% |
| 2020 | 7.73 | -25.51% |
| 2019 | 10.38 | -15.78% |
| 2018 | 12.33 | -8.64% |
| 2017 | 13.49 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 4.11% |
IN
|
